Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 199.56B P/E 6.97 EPS this Y 20.10% Ern Qtrly Grth -
Income 2.13B Forward P/E 11.51 EPS next Y 23.50% 50D Avg Chg -6.00%
Sales 58.5B PEG -8.59 EPS past 5Y 0.52% 200D Avg Chg -17.00%
Dividend 5.00% Price/Book 1.98 EPS next 5Y -1.33% 52W High Chg -36.00%
Recommedations 2.50 Quick Ratio 0.58 Shares Outstanding 5.66B 52W Low Chg -
Insider Own 0.05% ROA 1.55% Shares Float 5.64B Beta 0.57
Inst Own 69.94% ROE 2.35% Shares Shorted/Prior 68.06M/71.65M Price 35.35
Gross Margin 58.99% Profit Margin 3.62% Avg. Volume 26,886,577 Target Price 31.10
Oper. Margin -49.97% Earnings Date May 1 Volume 34,241,200 Change -0.73%
About Pfizer, Inc.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Pfizer, Inc. News
05:17 PM A Big Week For The Stock Market: Apple, Amazon, Big Pharma And The Fed
03:30 PM FDA Green Lights Pfizer's Gene Therapy For Rare Bleeding Disorder Hemophilia
03:07 PM Pfizer Wins FDA Approval For $3.5 Million Gene Therapy, Rivaling CSL, Uniqure
02:57 PM Sector Update: Health Care Stocks Edge Higher Late Afternoon
12:24 PM Pfizer Gets FDA Approval for Bleeding Disorder Treatment
09:14 AM Pfizer Receives FDA Approval for Bleeding Disorder Treatment
08:15 AM Gear Up for Pfizer (PFE) Q1 Earnings: Wall Street Estimates for Key Metrics
07:45 AM AbbVie (ABBV) Beats Q1 Earnings and Revenue Estimates
06:45 AM Want $2,000 in Annual Dividends? Invest $30,000 in These 3 Stocks
06:00 AM UPDATE 2-US FDA approves Pfizer's gene therapy for rare bleeding disorder
05:53 AM Pfizer hemophilia gene therapy arrives in US to uncertain future
05:45 AM U.S. FDA Approves Pfizer’s BEQVEZ™ (fidanacogene elaparvovec-dzkt), a One-Time Gene Therapy for Adults with Hemophilia B
03:50 AM Should You Buy Moderna Before May 12?
04/25/24 Wall Street plunges after US inflation shock
04/25/24 Update: GSK Sues Pfizer, BioNTech Over mRNA Patents in Covid-19 Vaccines
04/25/24 Heard on the Street: Bristol-Myers Goes From Big Pharma to Little Pharma
04/25/24 UPDATE 3-GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
04/25/24 GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
04/25/24 UPDATE 1-Ad group WPP reports 1.6% drop in first-quarter organic growth
04/24/24 Pfizer Declares Second-Quarter 2024 Dividend
PFE Chatroom

User Image DocPharm Posted - 11 minutes ago

$PFE still mind boggling - still adding biweekly here

User Image NT22 Posted - 27 minutes ago

@ScamHedgefunds na. That’s risky. DARPA has a bird flu mrna vaccine just waiting to stick $PFE and $MRNA label on it. Just like they did the COVD19 vaxx. No one would have taken it if they knew it was a .gov vacks. Soft kill depop weapons though. Get a weird cancer in 3 years and no one suspects it. It comes down to the production method. For the clinical batches the used a cho cell based process. Mammalian cell products are easy to purify in small batches. When they scaled up they used a fermentation process and it was contaminated with plasmid DNA. I know, my team sold the viral vectors to the pilot lab.

User Image OU12 Posted - 33 minutes ago

$PFE doubled my position here yesterday

User Image frankiefu Posted - 1 hour ago

$PFE https://www.pfizer.com/science/innovation/gene-therapy

User Image nimaa Posted - 1 hour ago

$PFE buy discounted sell @40 💰

User Image Synthetic_trades Posted - 1 hour ago

$PFE going to settle out at 35 next year. This is probably bottom.

User Image NEWBIGTECH Posted - 1 hour ago

$AMGN $JNJ $PFE $RHHBY $ENSC

User Image twincam Posted - 2 hours ago

$CRDF IMO, ER on May 2 will likely include report on P/A with $PFE . GLTA 💰💰💰

User Image wahoowa96 Posted - 2 hours ago

$PFE Let me give you best weight loss treatment guaranteed to lose 50 lbs in 4 months. Ride this weekly bike ride plan year-round. It will return better results than LILLY Zepbound. Don’t waste your money with Lilly. https://fulgaz.com/grand-tour-training-camp/

User Image wahoowa96 Posted - 3 hours ago

$PFE Vertex & CRISPR should be very salty today with today’s hemophilia. There’s more to come - thalassemia and sickle cell disease. When Pfizer acquired GBT in 2022 that was already in the plan! So buckle up Vertex, CRIPR, and CSL!

User Image LockStocksandBarrel Posted - 3 hours ago

$PFE Next Wednesday should be interesting…I wonder if all the bad news has been priced in or not. I guess we wait and see.

User Image wahoowa96 Posted - 3 hours ago

$PFE someone dig Arcturus’s lipid based mRNA delivery system and mRNA vaccines studies and see if GSK claims were allowed by oversight.

User Image wahoowa96 Posted - 4 hours ago

$PFE Challenge GSK patents all of them. Find prior arts that can invalidate them. They were issued patents in 2023 and Covid vaccines were made in 2021-2022. Good timing GSK?!!

User Image NT22 Posted - 4 hours ago

$PFE and $MRNA are really shaking things up in the gene therapy… i mean vacsine market.

User Image taxplanr Posted - 4 hours ago

Pissed off injured footballer is suing $BNTX $PFE can $MRNA hear the clock ticking https://x.com/Censored4sure/status/1783919476506771620

User Image serier Posted - 4 hours ago

$PFE good news, bad news..a shit. Will be selling at the first opportunity.

User Image pfelinepfrenzy1990 Posted - 4 hours ago

$PFE - EoD duckery. Totally expected. MMs are getting ready for the ER. Crooks.

User Image F_I_R_E_ Posted - 4 hours ago

$PFE fda approval means nothing. $TSLA misses biggest revenue decline in 10 years and it goes up. Someone make sense of this market

User Image cat0 Posted - 4 hours ago

$PFE -Mirror, mirror on the wall, who's the fairest of them all? -BOURLA!

User Image jakecollyflower Posted - 4 hours ago

$PFE down 4%, up barely 1%. Rinse and repeat

User Image Kylenorth Posted - 4 hours ago

$PFE lets finish red!!!!

User Image Kylenorth Posted - 5 hours ago

$PFE thats the gift today. next leg down begins monday

User Image cat0 Posted - 5 hours ago

$PFE America's Got Talent https://www.worldfinance.com/profile/the-man-who-saved-the-world

User Image hingfdiuh Posted - 5 hours ago

$PFE bought 20 May 3 $27.5 calls for $0.06 each and 10 May 10 $27.5 calls for $0.09 each … 10% earnings blowout next week!

User Image LockStocksandBarrel Posted - 5 hours ago

$PFE Why is this up 1% today?

User Image Stocksrunner Posted - 5 hours ago

📈 Market Alert: Unusual Options Activity 🚀 $PFE Look at What the Big Money is Thinking. Deep-pocketed investors lean bullish with 27 unusual trades spotted. https://stocksrunner.com/symbol/pfe

User Image Youngbuffet420 Posted - 5 hours ago

$PFE fda news and this up not even a percent…. Joke… $26 calls are gonna print

User Image NEWBIGTECH Posted - 6 hours ago

$ENSC is looking for a partner to help with Opioid Addiction. Has FDA Approval on for its PF614-MPAR® technology. SO Does it get $JNJ $AMGN $PFE or $RHHBY .. Get the word out, maybe competing Bids for this Technology. Who has the made an offer? Are they aware that $ENSC is the only Drug company with this technology?

User Image dayandswing22 Posted - 6 hours ago

$PFE yay. I’m not selling here though Who is??

User Image JimiJoJeeter Posted - 6 hours ago

@Mike909067777 It's a game of chicken. $PFE knows that $SGMO investors nor the BOD want a reverse split to keep the doors open; however, $PFE wantS to get something for nothing..... In the meantime, shareholders tend to get screwed!

Analyst Ratings
Cantor Fitzgerald Overweight Apr 18, 24
Cantor Fitzgerald Overweight Apr 15, 24
Cantor Fitzgerald Overweight Apr 5, 24
Cantor Fitzgerald Overweight Apr 1, 24
Argus Research Hold Mar 22, 24
Cantor Fitzgerald Overweight Mar 4, 24
Cantor Fitzgerald Overweight Mar 1, 24
Guggenheim Buy Feb 23, 24
Cantor Fitzgerald Overweight Jan 31, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Gottlieb Scott Director Director Dec 15 Buy 26.4670 3,000 79,401 9,000 12/19/23
McDermott Michael Executive Vice Presi.. Executive Vice President Feb 25 Option 22.89 14,178 324,534 93,099 02/28/23
DAMICO JENNIFER B. SVP & Controller SVP & Controller Feb 25 Option 22.89 11,150 255,224 27,893 02/28/23
SUSMAN SALLY Executive Vice Presi.. Executive Vice President Feb 25 Option 22.89 72,984 1,670,604 209,179 02/28/23
Hwang Angela President, Global Bi.. President, Global Biopharma Feb 25 Option 22.89 20,273 464,049 44,541 02/28/23
JOHNSON RADY A Executive Vice Presi.. Executive Vice President Feb 25 Option 22.89 33,654 770,340 116,473 02/28/23
Hwang Angela President, Global Bi.. President, Global Biopharmaceu Feb 22 Option 30.17 57,032 1,720,655 67,027 02/24/23
SUSMAN SALLY Executive Vice Presi.. Executive Vice President Feb 22 Option 30.17 76,043 2,294,217 195,493 02/24/23
SAHNI PAYAL Executive Vice Presi.. Executive Vice President Feb 22 Option 30.17 15,209 458,856 32,671 02/24/23
McDermott Michael Executive Vice Presi.. Executive Vice President Feb 22 Option 30.17 13,307 401,472 88,957 02/24/23
JOHNSON RADY A Executive Vice Presi.. Executive Vice President Feb 22 Option 30.17 31,558 952,105 106,556 02/24/23
DAMICO JENNIFER B. SVP & Controller SVP & Controller Feb 22 Option 30.17 10,456 315,458 21,584 02/24/23
LANKLER DOUGLAS M Executive Vice Presi.. Executive Vice President Dec 14 Option 26.53 101,658 2,696,987 180,461 12/16/22
BOURLA ALBERT Chairman & CEO Chairman & CEO Dec 15 Option 26.53 222,328 5,898,362 411,890 12/16/22
DAMICO JENNIFER B. SVP & Controller SVP & Controller May 13 Sell 50.5000 4,000 202,000 15,064 05/17/22
SAHNI PAYAL Executive Vice Presi.. Executive Vice President May 13 Sell 49.8400 1,408 70,175 17,372 05/16/22
Carapezzi William R JR Executive Vice Presi.. Executive Vice President May 12 Sell 50.0000 32,908 1,645,400 38,146 05/13/22
LANKLER DOUGLAS M Executive Vice Presi.. Executive Vice President May 12 Sell 49.4100 38,273 1,891,069 78,803 05/13/22
Dolsten Mikael President R&D President R&D May 11 Sell 49.34 63,902 3,152,925 333,342 05/12/22
SUSMAN SALLY Executive Vice Presi.. Executive Vice President Feb 26 Option 25.6 63,580 1,627,648 172,880 03/01/22
DAMELIO FRANK A Executive Vice Presi.. Executive Vice President Feb 26 Option 25.6 127,160 3,255,296 649,918 03/01/22
SUSMAN SALLY Executive Vice Presi.. Executive Vice President Feb 23 Option 27.34 76,895 2,102,309 166,470 02/25/22
SAHNI PAYAL Executive Vice Presi.. Executive Vice President Feb 23 Option 27.34 13,884 379,589 29,391 02/25/22
LANKLER DOUGLAS M Executive Vice Presi.. Executive Vice President Feb 23 Option 27.34 115,342 3,153,450 181,659 02/25/22
JOHNSON RADY A Executive Vice Presi.. Executive Vice President Feb 23 Option 27.34 35,457 969,394 91,301 02/25/22
Hwang Angela Group President Group President Feb 23 Option 27.34 21,359 583,955 21,359 02/25/22
DAMELIO FRANK A Executive Vice Presi.. Executive Vice President Feb 23 Option 27.34 153,789 4,204,591 636,977 02/25/22
DAMICO JENNIFER B. SVP & Controller SVP & Controller Feb 23 Option 27.34 11,748 321,190 21,668 02/25/22
Carapezzi William R JR Executive Vice Presi.. Executive Vice President Feb 23 Option 27.34 25,632 700,779 82,914 02/25/22
YOUNG JOHN D Group President Group President Nov 11 Sell 50.09 150,000 7,513,500 312,704 11/12/21